Additionally, the activation of TLR3 following the poly(I:C) treatment resulted in a rise in cell death in the TLR3+ SNU182 hepatocellular carcinoma cell line while also enhancing stimulation of NK cells and their cytotoxicity by 4-fold in vitro [35]. Here, TLR3 is linked to hepatocellular carcinoma.